Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients
Taylor B. Crawford, Maliha N Tayeb, Emanuel Barrett, Tara Al-Saleem, Pranavi Kondam, Ryan M. Hausler, Heather Symecko, Caitlin Orr, Catherine Wolfe, Derek Mann, Kelsey Spielman, Gloria Wong, Naomi Balzer Haas, Vivek Narayan, Kyle William Robinson, , Kara N. Maxwell
This study reports a 5.4% rate of pathogenic germline variants in a racially diverse cohort of prostate cancer patients, with significant associations between PGV rates and age at diagnosis and self-identified race.
Journal of the National Comprehensive Cancer Network · Jun 2, 2026Peer-reviewedGenetic & Genomic Medicine